Study for the Treatment of Transfusional Iron Overload in Myelodysplastic Patients

Clinical trial NCT00117507 · COMPLETED

Trial details

NCT number: NCT00117507
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Iron Overload

Start date: 2005-09-01
Primary completion: 2008-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.